- Original brands
- The price on the pack
Privacy: may we measure how you found us? Never your name, number or health details.
May we remember how you found us, so we know which adverts are worth running? Allowing advertising also shares the value of a confirmed booking or payment, and the ad click it came from, with Google. We never share your name, contact details, medicines or anything about your health.

MRP, inclusive of all taxes
Delivered across India. ₹49 delivery, free above ₹999.
Pack: 1X3ML
Prescription required — upload during checkout. No prescription? Place the order and a doctor will call you free of charge before it ships.
Original brandsFrom authorised sources
The price on the packNo inflated MRPs
Licensed pharmacyRx checked before packing
7 days to report a problemWrong or damaged item
Contains: Liraglutide 6 mg/mL solution for injection (prefilled pen 3 mL; total 18 mg)
Victoza Liraglutid Pen contains Liraglutide 6 mg/mL solution for injection (prefilled pen 3 mL; total 18 mg). Prescription required.
We'll let you know the moment Victoza Liraglutid Pen is back in stock.
Victoza Liraglutid Pen is a prescription medicine containing Liraglutide 6 mg/mL solution for injection (prefilled pen 3 mL; total 18 mg). It is used for type 2 diabetes mellitus (as an adjunct to diet, exercise to improve glycaemic control) and chronic weight management in adults with obesity. It belongs to the group of medicines called GLP-1 receptor agonist (incretin mimetic).
Subcutaneous injection once daily at the same time each day, independent of meals. The dose and how long you take it depend on what you are being treated for and how you respond. Do not take more, or for longer, than your doctor has advised.
The side effects seen most often with Victoza Liraglutid Pen are nausea, vomiting, diarrhoea and constipation. Most are mild and settle as the body gets used to the medicine. Tell your doctor if one persists or worries you.
Before you start, tell your doctor about any liver, kidney or heart problem, whether you are pregnant, planning a pregnancy or breastfeeding, and every other medicine you take, including supplements and ayurvedic preparations. Some of them can change how Victoza Liraglutid Pen works.
Lowers fasting and post-meal blood glucose, Helps reduce HbA1c, Supports weight loss via appetite reduction, Lowers risk of hypoglycaemia when not combined with insulin/sulfonylurea, Convenient once-daily injection
Most side effects of Victoza Liraglutid Pen are mild and settle as the body gets used to the medicine. The ones reported most often are:
Stop the medicine and get help at once for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.
Subcutaneous injection once daily at the same time each day, independent of meals. Inject into abdomen, thigh, or upper arm; rotate sites and do not inject intravenously or intramuscularly. Typical titration: start 0.6 mg daily for 1 week, then 1.2 mg daily; may increase to 1.8 mg daily if needed (as directed by doctor). Use a new needle each time and follow pen instructions.
Liraglutide is a GLP-1 receptor agonist that increases glucose-dependent insulin secretion and reduces inappropriate glucagon release. It also slows gastric emptying and reduces appetite, helping lower blood glucose and support weight loss.
Not for type 1 diabetes or diabetic ketoacidosis. Risk of pancreatitis—seek urgent care for severe persistent abdominal pain (with/without vomiting). Contraindicated/avoid in patients with personal/family history of medullary thyroid carcinoma or MEN2; report neck lump/hoarseness/dysphagia. Use caution in severe GI disease (e.g., gastroparesis) and in renal impairment due to dehydration from GI side effects; monitor kidney function if significant vomiting/diarrhoea occurs. Monitor for gallbladder disease symptoms. Hypoglycaemia risk increases when used with insulin or sulfonylureas—dose adjustment may be needed. Do not share pens; use only with compatible needles.
Insulin and sulfonylureas (increased hypoglycaemia risk), other GLP-1 receptor agonists (not recommended together), drugs with narrow therapeutic index requiring rapid GI absorption may be affected due to delayed gastric emptying (monitor), warfarin/anticoagulants (monitor INR on initiation/titration), alcohol (may increase hypoglycaemia risk)
Store unopened pens refrigerated at 2–8°C; do not freeze and keep away from freezer compartment. After first use, store refrigerated (2–8°C) or at room temperature (up to 30°C) as per label; protect from light, keep cap on, and discard after the in-use period stated on pack (commonly 30 days). Do not use if solution is cloudy/colored or contains particles.
Saxenda (liraglutide) pen, Victoza 3 mL Pen (liraglutide) - other pack/label, Ozempic (semaglutide) pen, Trulicity (dulaglutide) pen, Rybelsus (semaglutide) tablets
Compiled from the manufacturer's prescribing information and the sources below, and reviewed by a registered pharmacist. It does not replace your own doctor's advice.
Medical disclaimer: product information is for awareness only and does not replace medical advice. For Rx medicines, a valid prescription is required. Consult your doctor or pharmacist for personalised guidance.
Serum Institute of India Ltd
Injection · 25 mg · 1 ml
₹142.50
Prescription needed
CIPLA Limited
Respule · 5 Respules
₹127.13
Prescription needed